Genome Editing From Modeling Disease to Novel Therapeutics

The ability of human pluripotent stem cells (hPSCs) to differentiate into the many specialized cell types of the human body holds great promise for the study and treatment of human disease. Genome editing of hPSCs can allow for more accurate modeling of human diseases by introducing disease-specific mutations, or correct genetic aberrations in patient-derived induced pluripotent stem cell lines. Advances in tools such as transcription activator-like effector nucleases (TALENs) or clustered regularly interspaced short palindromic repeat (CRISPR) technologies have improved the ease and efficiency of genome editing in hPSCs.
Watch this free webinar featuring Dr. Chad Cowan (Harvard University) to learn how you can modify hPSC genomes and enhance the physiological relevance of your research.
  • Culture conditions for expansion and cloning of hPSCs
  • Design and use of TALENs or CRISPRs with hPSCs
  • Identification of clones without antibiotic selection
  • Applications of modified hPSCs including disease modeling
  • Use of the CRISPR/Cas system for gene therapy
Publish Date: June 20, 2014 Views: 0

Contact STEMCELL Technologies

Our Customer Service, Sales, and Product and Scientific Support departments in North America are available between 6 am and 5 pm Pacific Time (9 am and 8 pm Eastern Time). One of our representatives will be happy to help you by telephone or email. Please complete the form to contact us by email. A representative will get back to you shortly.

StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.